Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Not applicable Interventional Results available

A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols

ClinicalTrials.gov ID: NCT01369433

Public ClinicalTrials.gov record NCT01369433. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 9:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01369433
Recruitment status
Terminated
Study type
Interventional
Phase
Not applicable
Lead sponsor
AVEO Pharmaceuticals, Inc.
Industry
Enrollment
225 participants

Conditions and interventions

Conditions

Interventions

  • Tivozanib + paclitaxel Drug
  • Tivozanib + temsirolimus Drug
  • Tivozanib Drug
  • Tivozanib (AV-951) Drug
  • Tivozanib + capecitabine Drug
  • Tivo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2010
Primary completion
May 31, 2015
Completion
Sep 30, 2015
Last update posted
Aug 31, 2020

2010 – 2015

United States locations

U.S. sites
27
U.S. states
21
U.S. cities
27
Facility City State ZIP Site status
Translational Genomics Research Institute (TGEN) Scottsdale Arizona 85258
Institute of Urologic Oncology Los Angeles California 90024
Stanford University Stanford California 94305
Not listed Aurora Colorado 80010
Florida Cancer Specialists Fort Myers Florida 33905
H. Lee Moffitt Cancer Center & Research Institute Hospital, Inc Tampa Florida 33612
Not listed Beech Grove Indiana 46107
Horizon Oncology Research, Inc. Lafayette Indiana 47905
Not listed Wichita Kansas 57217
Medical Oncology LLC Baton Rouge Louisiana 70801
Jayne Gurtler MD, Laura Brinz MD, Angelo Russo MD and Janet Burroff MD APMC Metairie Louisiana 70006
Associates in Oncology/Hematology Rockville Maryland 20850
Dana Farber Cancer Institute Boston Massachusetts 02115
Not listed Grand Rapids Michigan 49501
Not listed Tupelo Mississippi 38801
Nebraska Methodist Hospital Omaha Nebraska 68114
Not listed Las Vegas Nevada 88901
Not listed Lebanon New Hampshire 03748
Not listed Chapel Hill North Carolina 27514
Not listed Columbus Ohio 43004
The OU Cancer Institute Oklahoma City Oklahoma 73117
Not listed Philadelphia Pennsylvania 19019
Sarah Cannon Research Institute (SCRI) Nashville Tennessee 37203
Not listed Austin Texas 73301
Coastal Bend Cancer Center Corpus Christi Texas 78336
Not listed Dallas Texas 75001
Not listed Tacoma Washington 98402

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01369433, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 31, 2020 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01369433 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →